UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
![]() |
|||||||
|
Fusion Protein:FUNDC2-ITPR2 |
Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: FUNDC2-ITPR2 | FusionPDB ID: 31775 | FusionGDB2.0 ID: 31775 | Hgene | Tgene | Gene symbol | FUNDC2 | ITPR2 | Gene ID | 65991 | 3709 |
Gene name | FUN14 domain containing 2 | inositol 1,4,5-trisphosphate receptor type 2 | |
Synonyms | DC44|HCBP6|HCC3|PD03104 | ANHD|CFAP48|INSP3R2|IP3R2 | |
Cytomap | Xq28 | 12p11.23 | |
Type of gene | protein-coding | protein-coding | |
Description | FUN14 domain-containing protein 2HCC-3cervical cancer oncogene 3cervical cancer proto-oncogene 3 proteinhepatitis C virus core-binding protein 6 | inositol 1,4,5-trisphosphate receptor type 2IP3 receptorIP3R 2cilia and flagella associated protein 48type 2 InsP3 receptor | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | Q9BWH2 | Q14571 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000484175, ENST00000369498, | ENST00000381340, ENST00000242737, ENST00000545902, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 1 X 1 X 1=1 | 27 X 21 X 12=6804 |
# samples | 1 | 27 | |
** MAII score | log2(1/1*10)=3.32192809488736 | log2(27/6804*10)=-4.65535182861255 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: FUNDC2 [Title/Abstract] AND ITPR2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | FUNDC2(154261828)-ITPR2(26943160), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | FUNDC2-ITPR2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. FUNDC2-ITPR2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | ITPR2 | GO:0001666 | response to hypoxia | 19120137 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Fusion Gene Sample Information |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | SARC | TCGA-DX-A1KZ | FUNDC2 | chrX | 154261828 | + | ITPR2 | chr12 | 26943160 | - |
Top |
Fusion ORF Analysis |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000369498 | FUNDC2 | chrX | 154261828 | + | ENST00000381340 | ITPR2 | chr12 | 26943160 | - | 10540 | 538 | 254 | 8551 | 2765 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000369498 | ENST00000381340 | FUNDC2 | chrX | 154261828 | + | ITPR2 | chr12 | 26943160 | - | 0.000456962 | 0.9995431 |
Top |
Fusion Amino Acid Sequences |
![]() |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >31775_31775_1_FUNDC2-ITPR2_FUNDC2_chrX_154261828_ENST00000369498_ITPR2_chr12_26943160_ENST00000381340_length(amino acids)=2765AA_BP=95 METSAPRAGSQVVATTARHSAAYRADPLRVSSRDKLTEMAASSQGNFEGNFESLDLAEFAKKQPWWRKLFGQESGPSAEKYSVATQLFIG GVTGWLVDDRCVVHPEAGDLANPPKKFRDCLFKVCPMNRYSAQKQYWKAKQAKQGNHTEAALLKKLQHAAELEQKQNESENKKLLGEIVK YSNVIQLLHIKSNKYLTVNKRLPALLEKNAMRVSLDAAGNEGSWFYIHPFWKLRSEGDNIVVGDKVVLMPVNAGQPLHASNIELLDNPGC KEVNAVNCNTSWKITLFMKYSSYREDVLKGGDVVRLFHAEQEKFLTCDEYEKKQHIFLRTTLRQSATSATSSKALWEIEVVHHDPCRGGA GQWNSLFRFKHLATGNYLAAELNPDYRDAQNEGKNVRDGVPPTSKKKRQAGEKIMYTLVSVPHGNDIASLFELDATTLQRADCLVPRNSY VRLRHLCTNTWVTSTSIPIDTDEERPVMLKIGTCQTKEDKEAFAIVSVPLSEVRDLDFANDANKVLATTVKKLENGTITQNERRFVTKLL EDLIFFVADVPNNGQEVLDVVITKPNRERQKLMREQNILAQVFGILKAPFKEKAGEGSMLRLEDLGDQRYAPYKYMLRLCYRVLRHSQQD YRKNQEYIAKNFCVMQSQIGYDILAEDTITALLHNNRKLLEKHITAKEIETFVSLLRRNREPRFLDYLSDLCVSNTTAIPVTQELICKFM LSPGNADILIQTKVVSMQADNPMESSILSDDIDDEEVWLYWIDSNKEPHGKAIRHLAQEAKEGTKADLEVLTYYRYQLNLFARMCLDRQY LAINQISTQLSVDLILRCVSDESLPFDLRASFCRLMLHMHVDRDPQESVVPVRYARLWTEIPTKITIHEYDSITDSSRNDMKRKFALTME FVEEYLKEVVNQPFPFGDKEKNKLTFEVVHLARNLIYFGFYSFSELLRLTRTLLAILDIVQAPMSSYFERLSKFQDGGNNVMRTIHGVGE MMTQMVLSRGSIFPMSVPDVPPSIHPSKQGSPTEHEDVTVMDTKLKIIEILQFILSVRLDYRISYMLSIYKKEFGEDNDNAETSASGSPD TLLPSAIVPDIDEIAAQAETMFAGRKEKNPVQLDDEGGRTFLRVLIHLIMHDYPPLLSGALQLLFKHFSQRAEVLQAFKQVQLLVSNQDV DNYKQIKADLDQLRLTVEKSELWVEKSSNYENGEIGESQVKGGEEPIEESNILSPVQDGTKKPQIDSNKSNNYRIVKEILIRLSKLCVQN KKCRNQHQRLLKNMGAHSVVLDLLQIPYEKNDEKMNEVMNLAHTFLQNFCRGNPQNQVLLHKHLNLFLTPGLLEAETMRHIFMNNYHLCN EISERVVQHFVHCIETHGRHVEYLRFLQTIVKADGKYVKKCQDMVMTELINGGEDVLIFYNDRASFPILLHMMCSERDRGDESGPLAYHI TLVELLAACTEGKNVYTEIKCNSLLPLDDIVRVVTHDDCIPEVKIAYVNFVNHCYVDTEVEMKEIYTSNHIWKLFENFLVDMARVCNTTT DRKHADIFLEKCVTESIMNIVSGFFNSPFSDNSTSLQTHQPVFIQLLQSAFRIYNCTWPNPAQKASVESCIRTLAEVAKNRGIAIPVDLD SQVNTLFMKSHSNMVQRAAMGWRLSARSGPRFKEALGGPAWDYRNIIEKLQDVVASLEHQFSPMMQAEFSVLVDVLYSPELLFPEGSDAR IRCGAFMSKLINHTKKLMEKEEKLCIKILQTLREMLEKKDSFVEEGNTLRKILLNRYFKGDYSIGVNGHLSGAYSKTAQVGGSFSGQDSD KMGISMSDIQCLLDKEGASELVIDVIVNTKNDRIFSEGIFLGIALLEGGNTQTQYSFYQQLHEQKKSEKFFKVLYDRMKAAQKEIRSTVT VNTIDLGNKKRDDDNELMTSGPRMRVRDSTLHLKEGMKGQLTEASSATSKAYCVYRREMDPEIDIMCTGPEAGNTEEKSAEEVTMSPAIA IMQPILRFLQLLCENHNRELQNFLRNQNNKTNYNLVCETLQFLDCICGSTTGGLGLLGLYINEKNVALVNQNLESLTEYCQGPCHENQTC IATHESNGIDIIIALILNDINPLGKYRMDLVLQLKNNASKLLLAIMESRHDSENAERILFNMRPRELVDVMKNAYNQGLECDHGDDEGGD DGVSPKDVGHNIYILAHQLARHNKLLQQMLKPGSDPDEGDEALKYYANHTAQIEIVRHDRTMEQIVFPVPNICEYLTRESKCRVFNTTER DEQGSKVNDFFQQTEDLYNEMKWQKKIRNNPALFWFSRHISLWGSISFNLAVFINLAVALFYPFGDDGDEGTLSPLFSVLLWIAVAICTS MLFFFSKPVGIRPFLVSIMLRSIYTIGLGPTLILLGAANLCNKIVFLVSFVGNRGTFTRGYRAVILDMAFLYHVAYVLVCMLGLFVHEFF YSFLLFDLVYREETLLNVIKSVTRNGRSIILTAVLALILVYLFSIIGFLFLKDDFTMEVDRLKNRTPVTGSHQVPTMTLTTMMEACAKEN CSPTIPASNTADEEYEDGIERTCDTLLMCIVTVLNQGLRNGGGVGDVLRRPSKDEPLFAARVVYDLLFYFIVIIIVLNLIFGVIIDTFAD LRSEKQKKEEILKTTCFICGLERDKFDNKTVSFEEHIKSEHNMWHYLYFIVLVKVKDPTEYTGPESYVAQMIVEKNLDWFPRMRAMSLVS -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chrX:154261828/chr12:26943160) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
FUNDC2 | ITPR2 |
FUNCTION: Receptor for inositol 1,4,5-trisphosphate, a second messenger that mediates the release of intracellular calcium. This release is regulated by cAMP both dependently and independently of PKA (By similarity). {ECO:0000250|UniProtKB:Q9Z329}. |
![]() |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000242737 | 0 | 6 | 112_166 | 30.666666666666668 | 182.0 | Domain | MIR 1 | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000242737 | 0 | 6 | 173_223 | 30.666666666666668 | 182.0 | Domain | MIR 2 | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000242737 | 0 | 6 | 231_287 | 30.666666666666668 | 182.0 | Domain | MIR 3 | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000242737 | 0 | 6 | 294_372 | 30.666666666666668 | 182.0 | Domain | MIR 4 | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000242737 | 0 | 6 | 378_434 | 30.666666666666668 | 182.0 | Domain | MIR 5 | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000381340 | 0 | 57 | 112_166 | 30.666666666666668 | 2702.0 | Domain | MIR 1 | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000381340 | 0 | 57 | 173_223 | 30.666666666666668 | 2702.0 | Domain | MIR 2 | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000381340 | 0 | 57 | 231_287 | 30.666666666666668 | 2702.0 | Domain | MIR 3 | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000381340 | 0 | 57 | 294_372 | 30.666666666666668 | 2702.0 | Domain | MIR 4 | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000381340 | 0 | 57 | 378_434 | 30.666666666666668 | 2702.0 | Domain | MIR 5 | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000242737 | 0 | 6 | 265_269 | 30.666666666666668 | 182.0 | Region | Inositol 1%2C4%2C5-trisphosphate binding | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000242737 | 0 | 6 | 507_510 | 30.666666666666668 | 182.0 | Region | Inositol 1%2C4%2C5-trisphosphate binding | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000242737 | 0 | 6 | 567_569 | 30.666666666666668 | 182.0 | Region | Inositol 1%2C4%2C5-trisphosphate binding | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000381340 | 0 | 57 | 265_269 | 30.666666666666668 | 2702.0 | Region | Inositol 1%2C4%2C5-trisphosphate binding | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000381340 | 0 | 57 | 507_510 | 30.666666666666668 | 2702.0 | Region | Inositol 1%2C4%2C5-trisphosphate binding | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000381340 | 0 | 57 | 567_569 | 30.666666666666668 | 2702.0 | Region | Inositol 1%2C4%2C5-trisphosphate binding | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000242737 | 0 | 6 | 2249_2260 | 30.666666666666668 | 182.0 | Topological domain | Extracellular | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000242737 | 0 | 6 | 2282_2307 | 30.666666666666668 | 182.0 | Topological domain | Cytoplasmic | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000242737 | 0 | 6 | 2329_2351 | 30.666666666666668 | 182.0 | Topological domain | Extracellular | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000242737 | 0 | 6 | 2373_2394 | 30.666666666666668 | 182.0 | Topological domain | Cytoplasmic | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000242737 | 0 | 6 | 2416_2521 | 30.666666666666668 | 182.0 | Topological domain | Extracellular | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000242737 | 0 | 6 | 2543_2701 | 30.666666666666668 | 182.0 | Topological domain | Cytoplasmic | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000381340 | 0 | 57 | 2249_2260 | 30.666666666666668 | 2702.0 | Topological domain | Extracellular | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000381340 | 0 | 57 | 2282_2307 | 30.666666666666668 | 2702.0 | Topological domain | Cytoplasmic | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000381340 | 0 | 57 | 2329_2351 | 30.666666666666668 | 2702.0 | Topological domain | Extracellular | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000381340 | 0 | 57 | 2373_2394 | 30.666666666666668 | 2702.0 | Topological domain | Cytoplasmic | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000381340 | 0 | 57 | 2416_2521 | 30.666666666666668 | 2702.0 | Topological domain | Extracellular | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000381340 | 0 | 57 | 2543_2701 | 30.666666666666668 | 2702.0 | Topological domain | Cytoplasmic | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000242737 | 0 | 6 | 2228_2248 | 30.666666666666668 | 182.0 | Transmembrane | Helical | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000242737 | 0 | 6 | 2261_2281 | 30.666666666666668 | 182.0 | Transmembrane | Helical | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000242737 | 0 | 6 | 2308_2328 | 30.666666666666668 | 182.0 | Transmembrane | Helical | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000242737 | 0 | 6 | 2352_2372 | 30.666666666666668 | 182.0 | Transmembrane | Helical | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000242737 | 0 | 6 | 2395_2415 | 30.666666666666668 | 182.0 | Transmembrane | Helical | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000242737 | 0 | 6 | 2522_2542 | 30.666666666666668 | 182.0 | Transmembrane | Helical | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000381340 | 0 | 57 | 2228_2248 | 30.666666666666668 | 2702.0 | Transmembrane | Helical | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000381340 | 0 | 57 | 2261_2281 | 30.666666666666668 | 2702.0 | Transmembrane | Helical | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000381340 | 0 | 57 | 2308_2328 | 30.666666666666668 | 2702.0 | Transmembrane | Helical | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000381340 | 0 | 57 | 2352_2372 | 30.666666666666668 | 2702.0 | Transmembrane | Helical | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000381340 | 0 | 57 | 2395_2415 | 30.666666666666668 | 2702.0 | Transmembrane | Helical | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000381340 | 0 | 57 | 2522_2542 | 30.666666666666668 | 2702.0 | Transmembrane | Helical |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000242737 | 0 | 6 | 1_2227 | 30.666666666666668 | 182.0 | Topological domain | Cytoplasmic | |
Tgene | ITPR2 | chrX:154261828 | chr12:26943160 | ENST00000381340 | 0 | 57 | 1_2227 | 30.666666666666668 | 2702.0 | Topological domain | Cytoplasmic |
Top |
Fusion Protein-Protein Interaction |
![]() |
![]() |
Gene | PPI interactors |
![]() |
Gene | STRING network |
FUNDC2 | |
ITPR2 | ![]() |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to FUNDC2-ITPR2 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to FUNDC2-ITPR2 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | ITPR2 | C0003132 | Anoxic Encephalopathy | 1 | CTD_human |
Tgene | ITPR2 | C0018800 | Cardiomegaly | 1 | CTD_human |
Tgene | ITPR2 | C0995195 | Anoxia of brain | 1 | CTD_human |
Tgene | ITPR2 | C1140716 | Hypoxic Brain Damage | 1 | CTD_human |
Tgene | ITPR2 | C1383860 | Cardiac Hypertrophy | 1 | CTD_human |
Tgene | ITPR2 | C1527348 | Brain Hypoxia | 1 | CTD_human |
Tgene | ITPR2 | C1862871 | ANHIDROSIS, ISOLATED, WITH NORMAL SWEAT GLANDS | 1 | CTD_human;ORPHANET;UNIPROT |